US Broker Ratings

BridgeBio Pharma (BBIO) Stock Analysis: Uncovering a 21.37% Potential Upside in Biotech

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is making waves in the biotech sector with its robust pipeline dedicated to genetic disease treatments. With a market capitalization of..

The Ensign Group, Inc. (ENSG) Stock Analysis: Eyeing a 30.73% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a formidable player in the healthcare sector, specializing in medical care facilities across the United States. With a..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Giant with a 14% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, boasting a robust market capitalization of $123.19 billion. Known for its transformative..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

Glaukos Corporation (GKOS) Stock Analysis: A Healthcare Innovator with a 5.57% Upside Potential

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, specifically within the medical devices industry, has been capturing investor attention with its innovative products..

Ionis Pharmaceuticals (IONS): Analyst Consensus Reveals 60% Upside Potential for This Biotech Innovator

For investors with an eye on the biotechnology sector, Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) presents a compelling opportunity. As a commercial-stage biotechnology company headquartered in Carlsbad,..

Guardant Health, Inc. (GH) Stock Analysis: Navigating High Growth in the Precision Oncology Market

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, has been capturing investor attention with its innovative solutions in cancer diagnostics and research. Headquartered in..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a Market Leader’s Potential Amidst Healthcare Innovation

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, stands as a compelling consideration for investors seeking exposure to the drug manufacturing industry. With a..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 37.52% Potential Upside in the Medical Devices Sector

As the healthcare sector continues its dynamic expansion, Globus Medical, Inc. (NYSE: GMED) stands out in the medical devices industry with a compelling investment case. With..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with 19.64% Upside Potential

argenx SE (ARGX), a prominent player in the biotechnology sector, has captured the attention of investors with its promising pipeline and impressive market performance. Based in..

Fresenius Medical Care AG (FMS) Stock Analysis: Insights into a 3.63% Dividend Yield and Growth Potential

Investors interested in the healthcare sector, particularly in medical care facilities, should pay close attention to Fresenius Medical Care AG (FMS). As a global leader in..

Agilent Technologies, Inc. (A) Stock Analysis: Is There a Potential 18.56% Upside for Investors?

Agilent Technologies, Inc. (NYSE: A), a formidable player in the healthcare sector, particularly within the diagnostics and research industry, presents an intriguing opportunity for investors with..

Qiagen N.V. (QGEN) Stock Analysis: Healthcare Innovator with a Promising 7.11% Upside

Qiagen N.V. (NYSE: QGEN), a prominent player in the healthcare sector, particularly within the diagnostics and research industry, is making headlines with its innovative approaches to..

Genmab A/S (GMAB) Stock Analysis: Unlocking a 26.68% Upside with Strong Buy Ratings

For investors seeking opportunities in the biotechnology sector, Genmab A/S (NASDAQ: GMAB) represents a compelling case with a significant potential upside. The Danish biotech company, boasting..

Pfizer, Inc. (PFE) Stock Analysis: Evaluating a 19.74% Potential Upside Amidst Market Volatility

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector and a key player in the drug manufacturing industry, presents a fascinating opportunity for investors seeking..

The Cooper Companies, Inc. (COO) Investor Outlook: A 14.67% Upside Potential Amid Healthcare Growth

Investors looking for opportunities in the healthcare sector may find The Cooper Companies, Inc. (NYSE: COO) an intriguing prospect, with analysts projecting a potential upside of..

Bruker Corporation (BRKR) Stock Analysis: Navigating Growth and Valuation Amidst Healthcare Sector Trends

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors seeking both innovation and stability...

Veeva Systems Inc. (VEEV) Investor Outlook: Unpacking the 28.65% Potential Upside

Veeva Systems Inc. (NYSE: VEEV), a stalwart in the healthcare sector, offers a compelling investment narrative with a potential upside of 28.65%, as indicated by analyst..

Waters Corporation (WAT) Stock Analysis: A Healthcare Leader with an 8.15% Upside Potential

Waters Corporation (NYSE: WAT) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a robust market cap of..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unveiling a 10% Upside Potential in the Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector with its innovative approach to drug delivery. With a market capitalization of $9.04 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds